Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laila Impex R&D Center is the research and development arm of the Laila Group, a leading Indian conglomerate specializing in standardized herbal extracts and nutraceutical ingredients. The center focuses on the discovery and development of evidence-based natural products for various health conditions, particularly inflammation, joint health, and metabolic disorders. Their work involves rigorous phytochemical standardization, preclinical screening, and human clinical trials to validate the efficacy and safety of their proprietary ingredients. Notable products developed by the center include 5-LOXIN and Aflapin, which are widely used globally in joint health supplements. The facility is recognized by the Department of Scientific and Industrial Research (DSIR), Government of India.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laila Impex R&D Center.